pANCA antibodies in patients with anterior uveitis: Identification of a marker antibody usually associated with ulcerative colitis

Journal of Clinical Immunology

Volumn 18, Issue 4, 1998, Pages 264-271

  Gordon, Lynn K ^a,b,d   Eggena, Mark ^c   Holland, Gary N ^a,b   Weisz, James M ^a   Braun, Jonathan ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JULES STEIN EYE INSTITUTE   (United States)

Author keywords

Autoantibody; pANCA; Ulcerative colitis; Uveitis

Indexed keywords

AUTOANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; MIDDLE AGED; UVEITIS, ANTERIOR;

EID: 0031876236     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027333822801     Document Type: Article

References (47)

1. Saxon A, Shanahan F, Landers C, Ganz T, Targan SR: A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 86:202-210, 1990
2. Mulder AH, Horst G, Haagsma EB, Kleibeuker JH, Kallenberg CG: Antineutrophil cytoplasmic antibodies (ANCA) in autoimmune liver disease. Adv Exp Med Biol 336:545-549, 1993
3. Orth T, Gerken G, Kellner R, Meyer zum Buschenfelde KH, Mayet WJ: Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1. J Hepatol 26:36-47, 1997
4. Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR: The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener ranulomatosis. Ann Intern Med 123:925-932, 1995
5. Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL: Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126: 866-873, 1997
6. Gaudin PB, Askin FB, Falk RJ, Jennette JC: The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeolperoxidase. Am J Clin Pathol 104:7-16, 1995
7. Spronk PE, Bootsma H, Horst G, Huitema MG, Limburg PC, Cohen Tervaert JW, Kallenberg CG: Antineutrophil cytoplasmic antibodies in systemic lupus erythematosis. Br J Rheum 35:625-631, 1996
8. Sobajima J, Ozaki S, Okazaki T, Osakada F, Sumita S, Mori K, Nakao K: Antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: Anti-cathepsin G and a novel antibody correlate with a refractory type. Clin Exp Immunol 105:120-124, 1996
9. Sung JY, Chan FK, Lawton J, Leung JC, Liew CT, Leung NW, Hsu R, Lai KN: Antineutrophil cytoplasmic antibodies (ANCA) and inflammatory bowel disease in Chinese. Dig Dis Sci 39:886-892, 1994
10. Schultz DR, Tozman EC: Antineutrophil cytoplasmic antibodies: Major autoantigens, pathophysiology, and disease associations. Semin Arth Rheum 25:143-159, 1995
11. Schnabel A, Hauschild S, Gross WL: Antineutrophil cytoplasmic antibodies in generalized autoimmune diseases. Int Arch Allergy Immunol 109:201-206, 1996
12. Vasiliauskas EA, Plevy SE, Landers CJ, Binder SW, Ferguson DM, Yang H, Rotter JI, Vidrich A, Targan SR: Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology 110:1810-1819, 1996
13. Jennings JG, Chang L, Savige JA: Anti-proteinase 3 antibodies, their characterization and disease associations. Clin Exp Immunol 95:251-256, 1994
14. Geffriaud-Ricouard C, Noel LH, Chaveau D, Houhou S, Grunfeld JP, Lasavre P: Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol 39:125-136, 1993
15. Yokota S, Tsubaki K, Kuriyama T, Shimizu Hm Ibe M, Mitsuda T, Aihara Y, Kosuge K, Nomaguchi H: Presence in Kawasaki disease of antibodies to mycobacterial heat-shock protein HSP65 and autoantibodies to epitopes of human HSP65 cognate antigen. Clin Immunol Immunopathol 67:163-170, 1993
16. Billing P, Tahir S, Calfin B, Gagne G, Cobb L, Targan S, Vidrich A: Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies. Am J Pathol 147:979-987, 1995
17. Vidrich A, Lee J, Cobb JE, Targan S: Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: Ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis. J Clin Immunol 15:293-299, 1995
18. Bansi DS, Chapman RW, Fleming KA: Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol 8:881-885, 1996
19. Bansi DS, Fleming KA, Chapman RW: Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass. Gut 38:384-389, 1996
20. Papo M, Quer JC, Pastor RM, Garcia-Pardo G, Prats E, Mirapeix E, Rodriguez R, Richart C: Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease. Am J Gastroenterol 91:1512-1515, 1996
21. Shanahan F, Duerr R, Landers C, Yang H, Sutherland L, Rotter J, Targan SR: Neutrophil antibodies in ulcerative colitis. A family study with evidence for genetic heterogeneity. Gastroenterology 103:456-461, 1992
22. Siebold R, Slameschka D, Gregor M, Weber F: Neutrophil autoantibodies: A genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 107:532-536, 1994
23. Vecchi M, Bianchi MB, Sinico RA, Radice A, Meucci G, Torgano G, Omodei P, Forzenigo L, Landoni M, Arrigoni M, Pozzi C, de Franchis R: Antibodies to neurophil cytoplasm in Italian patients with ulcerative colitis: Sensitivity, specificity, and recognition of putative antigens. Digestion 5:34-49, 1994
24. Tay-Kearney ML, Schwam BL, Lowder C, Dunn JP, Meisler DM, Vitale S, Jabs DA: Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol 121:47-56, 1996
25. McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG: Causes of uveitis in the general practice of ophthalmology. UCLA community-based uveitis study group. Am J Ophthalmol 121:35-46, 1996
26. Lyons JL, Rosenbaum JT: Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthamol 115:61-64, 1997
27. Weinberg RS: Anterior uveitis. Ophthalmol Clin NA 6:23-28, 1993
28. Deschenes J, Rocha G, Baines MG: Immunology of uveitis. Ophthalmol Clinics NA 6:1-11, 1993
29. Forrester JV: Duke Elder lecture: New concepts on the role of autoimmunity in the pathogenesis of uveitis. Eye 6:433-446, 1992
30. Soukiasian SH, Foster SC, Raizman MB: Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease. Am J Ophthalmol 118:601-611, 1994
31. Dutt S, Cartwright MJ, Nelson CC: Acute dacryoadenitis and Crohn's disease: Findings and management. Ophthal Plast Reconst Surg 8:295-299, 1992
32. Salmon JF, Wright JP, Murray AD: Ocular inflammation in Crohn's disease. Ophthalmology 98:480-484, 1991
33. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F: Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Gastroenterology 100:1590-1596, 1991
34. Eggena M, Targan SR, Iwanczyk L, Vidrich A, Gordon LK, Braun J: Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis. J Immunol 156:4005-4011, 1996
35. Hagen EC, Ballieux BEPB, Van Es LA, Daha MR, Van dey Woude FJ: Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. Blood 81:1996-2002, 1993
36. Kossa K, Coulthart A, Ives CT, Pusey CD, Hodgson HJ: Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol 7:783-789, 1995
37. Hertervig E, Wieslander J, Johansson C, Wiik A, Nilsson A: Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role, Scand J Gastroenterol 30:693-698, 1995
38. Bang la Cour B, Wiik A, Hoier-Madsen M, Baslund B: Clinical correlates and substrate specificities of antibodies exhibiting neutrophil nuclear reactivity - A methodological study. J Immunol Methods 187:287-295, 1995
39. Schultz DR, Tozman EC: Antineutrophil cytoplasmic antibodies: Major autoantigens, pathophysiology, and disease association. Semin Arth Rheum 25:143-159, 1995
40. Savige JA, Chang L, Wilson D, Buchanan RR: Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Rheum Int 16:109-114, 1996
41. Young DW: The antineutrophil antibody in uveitis. Br J Ophthalmol 75:208-211, 1991
42. Nolle B, Coners H, Duncker G: ANCA in ocular inflammatory disorders. Adv Exp Med Biol 336:305-307, 1993
43. Hagen EC, Van de Vijver-Reenalda H, de Keizer RJ, Kijlstra A, Van Es LA, Daha MR, Van der Woulds FJ: Uveitis and anti-neutrophil cytoplasmic antibodies. Clin Exp Immunol 95:56-69, 1994
44. Yu L, Rewers M, Gianni R, Kawasaki E, Zhang Y, Verge C, Chase P, Klingensmith G, Erlich H, Norris J: Antiislet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab 81:4264-4267, 1996
45. Kawasaki E, Eisenbarth GS, Wasmeier C, Hutton JC: Autoantibodies to protein tyrosin phosphatase-like proteins in type 1 diabetes. Overlapping specificities to phogrin and ICA 512/IA-2. Diabetes 45:1344-1349, 1996
46. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Chase HP, Eisenbarth GS: Number of autoantibodies (against insulin, GAD, or ICA512/IA1) rather than particular autoantibody specificities determines risk of type 1 diabetes. J Autoimmun 9:379-383, 1996
47. Baslund B, Szpirt W, Eriksson S, Elzouki AN, Wiik A, Wieslander J, Petersen J: Complexes between proteinase 3, alpha 1-antitrypsin, and proteinase 3 anti-neutrophil cytoplasmic autoantibodies: A comparison between alpha 1-antitrypsin PiZ allele carriers and non-carriers with Wegener's granulomatosis. Eur J Clin Invest 26:786-792, 1996